z-logo
open-access-imgOpen Access
Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancer
Author(s) -
Liam Ck
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.12.68
Subject(s) - osimertinib , epidermal growth factor receptor , mutant , lung cancer , central nervous system , cancer research , epidermal growth factor , lung , biology , receptor , medicine , oncology , neuroscience , genetics , erlotinib , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here